Strathcona Resources (SCR) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
5 Jun, 2025Executive summary
Reported year-end 2024 reserves with 2%–8% growth across PDP, 1P, and 2P categories; 2P reserves now 2,655 MMboe.
Full-year production averaged 183,080 boe/d (71% oil and condensate); Q4 production reached 187,203 boe/d.
Operating earnings for 2024 were $970.5 million ($4.53/share); free cash flow totaled $606.1 million ($2.83/share).
Quarterly dividend increased 4% to $0.26/share, payable March 31, 2025.
Financial highlights
Q4 2024 oil and natural gas sales, net of blending, were $1,024.6 million; full-year sales were $4,255.0 million.
Q4 operating earnings were $190.0 million ($0.89/share); Q4 free cash flow was $0.3 million, impacted by inventory build and deferred royalty deductions.
Full-year funds from operations reached $1,937.4 million; capital expenditures were $1,295.6 million, slightly below budget.
Net income for 2024 was $603.7 million, up from $587.2 million in 2023.
Outlook and guidance
2025 production to be re-evaluated mid-year after YTD 2025 production averaged ~195 Mboe/d, above guidance of 185–195 Mboe/d.
2025 capital budget remains at $1.35 billion.
Dividend increases will be considered with further production growth or lower breakeven prices.
Latest events from Strathcona Resources
- Five-year plan targets 10% CAGR to 200 Mbbls/d, leveraging long-life reserves and high margins.SCR
Corporate presentation25 Mar 2026 - Strong Q2, new dividend, and major carbon capture partnership; guidance updated for higher liquids.SCR
Q2 20241 Feb 2026 - Aiming for 8% annual growth, high returns, and major CCS projects through 2030.SCR
Investor Day 202414 Jan 2026 - Record production, MEG investment, and asset sales drive growth, liquidity, and synergies.SCR
Q1 202524 Dec 2025 - Organic growth prioritized, $10/share return planned if MEG deal fails, strong net income.SCR
Q2 202523 Nov 2025 - Q3 2025 saw strong earnings, a $10/share special distribution, and Cenovus deal update by December 1.SCR
Q3 202513 Nov 2025 - Q3 earnings and cash flow strong; 2025 targets growth and full free cash flow return to shareholders.SCR
Q3 202413 Jun 2025